Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study

6 de julho de 2018 atualizado por: Ron Victor, Cedars-Sinai Medical Center

Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men

African-American men suffer more than most other groups from hypertension (HTN) but often have less access and less contact with doctors. Previous work by the study's Principal Investigator in Dallas, Texas, and Altadena, California, showed that barbershops are an excellent place to identify black men with high blood pressure and to enlist the aid of their barbers as healthcare extenders.

The purpose of this study in Metro Los Angeles (LA) is to compare two types of barber-based patient-centered blood pressure programs to see which type is more effective in improving the customers' high blood pressure. One type emphasizes blood pressure medication and the other type emphasizes lifestyle modification for high blood pressure.

Visão geral do estudo

Descrição detalhada

Uncontrolled hypertension (HTN) is one of the most important causes of premature disability and death among non-Hispanic black men. Indeed, black men have the highest HTN death rate of any U.S. race, ethnic, or gender group, contributing to a lower life expectancy. The age-adjusted HTN-related death rate is 3.3-times higher among black men than white men. To address this major health disparity, the investigators designed a novel community-partnered team approach to improve HTN management among black men and prevent needless strokes, heart attacks, kidney failure, and heart failure.

HTN requires physician (or middle-level provider) interaction to optimize blood pressure (BP) medication; black men have less interaction than black women; and thus far lower rates of HTN treatment (73% vs. 86%) and control (36% vs. 50%). Black-owned barbershops are a uniquely personal setting to discuss health with influential male peers. Barbershop health outreach is well-established, but untested as a vehicle for improving HTN control. Scientific evaluation is crucial to best allocate finite healthcare dollars and avoid promoting a "community health industry" that benefits only the promoters.

Under-treatment of HTN is common in primary care due to competing demands on physicians' time. The best way to improve HTN control is with team-based approaches enlisting pharmacists. They are more accessible than physicians, more knowledgeable about medication, and receive training on patient education. The investigators' new conceptual model links the barber-based intervention to team-based care delivery.

The purpose of this research study is to compare this new conceptual model to another barber-based patient-centered blood pressure program to see which is more effective in improving high blood pressure among Black patrons of African American owned barbershops in LA. Patrons randomized to Group 1 (the new conceptual model) will provide blood pressure readings for patrons aged 35 to 79 years of age and refer those with HTN to a Clinical Pharmacist to work with their doctors in optimizing blood pressure medication.

Patrons of Group 1 shops will also be exposed to role model posters are not intended as recruitment materials, but rather are educational tools that intend to highlight positive experiences of participation. The text of the role model stories will in no way provide statements of the effectiveness of the intervention being evaluated by the present research study. Rather, they are the main health messaging tools needed to promote completion of the program in order to achieve the experiences described. Essentially the document will be used as an intervention tool for peer-based health messaging - stories from real customers in the barbershop modeling target behaviors leading that promote continued participation in the protocol by peers with the hopes of achieving to the detection, treatment, and control of high blood pressure. Each role model story will encourage one of two desired health behaviors of potential subjects with elevated BP: 1) ask the barber to check patients' BP with each haircut, 2) schedule a follow-up visit with the study pharmacist to get patient's blood pressure under control. Large posters in the barbershop will show the model customer, his barber, and the study pharmacist who facilitated the desired behavior change. The model's (participants) own words will be used on the poster.

Group 2 barbershop patrons will be exposed to up-to-date information on high blood pressure and on lifestyle topics for blood pressure and heart health including weight management, healthy cooking, cholesterol lowering, and exercise.

A pre-specified cross-sectional sub study utilized the trial's initial screening population to test for an association between self-reported nocturia (>2 nightly/voids) and elevated daytime (in-barbershop) blood pressure.

Tipo de estudo

Intervencional

Inscrição (Real)

320

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • California
      • Los Angeles, California, Estados Unidos, 90048
        • Cedars-Sinai Medical Center

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

35 anos a 79 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Macho

Descrição

Inclusion Criteria:

  • 35 to 79 years of age
  • Non-Hispanic Black men
  • Long-term/frequent barbershop patronage (barbershop patrons having at least one haircut every 6 weeks in the same barbershop for the past 6 months).
  • Systolic BP >140 at 2 screenings on 2 separate days
  • Complete set of Baseline Data

Exclusion Criteria:

  • Women
  • Children
  • <35 years of age
  • Non-black
  • Hispanic ethnicity
  • New/infrequent patronage (<8 haircuts at same barbershop in last 12 months)
  • Systolic BP <140 at either screening
  • Currently receiving cancer chemotherapy
  • On Dialysis
  • Incomplete baseline data
  • Serious Plan to Move in the next 1.5 years
  • Plans to be out of the area for > 1 month in the next 1.5 years

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: BP measurement & pharmacy
BP measurements performed by barber, role model poster exposure in barbershop, and BP medication management visits with study pharmacist
Blood pressure monitoring by barber, blood pressure medication management by pharmacist, role model posters encouraging program participation
Outro: BP educational materials
Exposure to hypertension educational materials in barbershop
Exposure to hypertension educational materials

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Primary Blood Pressure Outcome - change in systolic blood pressure
Prazo: 6 months
The pre-specified primary outcome was the change in systolic blood pressure from baseline to 6 months follow-up.
6 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Secondary Blood Pressure Outcome - change in diastolic blood pressure
Prazo: 6 months
The change in diastolic blood pressure from baseline to 6 month follow-up
6 months
The percentage of participants achieving blood pressure goal
Prazo: 6 months
The percentage of participants who achieved blood pressure goal after 6 months follow-up (140/90,135/85, 130/80)
6 months
The change in number/type of drug classes prescribed
Prazo: 6 months
The change in number/class of prescription drugs prescribed from baseline to 6 month follow-up
6 months
Adverse Drug Reactions
Prazo: 6 months
The number and type of adverse drug reactions reported from baseline to 6 month follow-up
6 months
Self-Rated Health
Prazo: 6 months
The change in self-rated health score from baseline to 6 month follow-up
6 months
Self-Rated Patient Engagement
Prazo: 6 months
The change in PACIC patient engagement score from baseline to 6 month follow-up
6 months

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Extension Study Primary Blood Pressure Outcome - change in systolic blood pressure
Prazo: 12 months
The primary outcome of the extension study is the change in systolic blood pressure from baseline to 12 months follow-up.
12 months
Extension Study Secondary Blood Pressure Outcome - change in diastolic blood pressure
Prazo: 12 months
The change in diastolic blood pressure from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - the percentage of participants achieving blood pressure goal
Prazo: 12 months
The percentage of participants who achieved blood pressure goal after 12 months follow-up (140/90,135/85, 130/80)
12 months
Extension Study Secondary Outcome - the change in number/type of drug classes prescribed
Prazo: 12 months
The change in number/class of prescription drugs prescribed from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - adverse drug reactions
Prazo: 12 months
The number and type of adverse drug reactions reported from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - self-rated health
Prazo: 12 months
The change in self-rated health from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - self-rated patient engagement
Prazo: 12 months
The change in PACIC patient engagement score from baseline to 12 month follow-up
12 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

17 de fevereiro de 2015

Conclusão Primária (Real)

30 de junho de 2017

Conclusão do estudo (Real)

9 de janeiro de 2018

Datas de inscrição no estudo

Enviado pela primeira vez

17 de dezembro de 2014

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de dezembro de 2014

Primeira postagem (Estimativa)

22 de dezembro de 2014

Atualizações de registro de estudo

Última Atualização Postada (Real)

10 de julho de 2018

Última atualização enviada que atendeu aos critérios de controle de qualidade

6 de julho de 2018

Última verificação

1 de julho de 2018

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • Pro00035347
  • 5R01HL117983-02 (Concessão/Contrato do NIH dos EUA)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em BP measurement & pharmacy

3
Se inscrever